Business Segments Edwards Lifesciences Corporation
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
16:00:03 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 90.75 USD | +0.60% |
|
+0.28% | +6.45% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Medical Products | 5.23B | 5.38B | 6B | 5.44B | 6.07B | |||||
Total Assets | 8.5B | 8.29B | 9.36B | 13.06B | 13.7B | |||||
Interest Expense | -18.4M | -19.2M | -17.6M | -19.8M | -20.4M | |||||
Income Tax Expense | 199M | 246M | 199M | 152M | 217M | |||||
CAPEX | -330M | -265M | -253M | -252M | -260M | |||||
EBT | 1.7B | 1.77B | 1.6B | 1.55B | 1.27B | |||||
Gross Profit | 3.98B | 4.3B | 4.62B | 4.32B | 4.73B | |||||
D&A | 135M | 140M | 145M | 155M | 157M | |||||
Operating Income | 1.69B | 1.75B | 1.53B | 1.38B | 1.26B | |||||
Net Income | 1.5B | 1.52B | 1.4B | 4.17B | 1.07B |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 2.96B | 3.13B | 3.51B | 3.21B | 3.54B | |||||
Total Assets | 1.2B | 1.19B | 1.27B | 1.25B | 1.26B | |||||
Operating Income | 2.05B | 2.13B | 2.31B | 2.16B | 2.34B | |||||
| - | - | - | - | 1.52B | ||||||
Europe | 1.19B | 1.17B | 1.33B | 1.32B | 1.52B | |||||
Total Assets | 198M | 192M | 196M | - | - | |||||
Operating Income | 569M | 652M | 710M | 725M | 796M | |||||
| - | - | - | - | 355M | ||||||
Rest of World | 550M | 601M | 709M | 572M | 652M | |||||
Total Assets | 336M | 332M | 354M | 535M | 655M | |||||
Operating Income | 185M | 248M | 310M | 243M | 298M | |||||
| - | - | - | - | 3.54B | ||||||
Japan | 529M | 474M | 452M | 340M | 355M | |||||
Total Assets | 19.7M | 13.2M | 23.8M | - | - | |||||
Operating Income | 348M | 377M | 259M | 213M | 234M | |||||
Operating Income | -1.61B | -1.71B | -1.92B | - | - | |||||
| - | - | - | - | 652M |
- Stock Market
- Stocks
- EW Stock
- Financials Edwards Lifesciences Corporation
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
